New Products
Cytosections for Antibody Screening AMS Biotechnology (AMSBIO) has launched a comprehensive range of cytosections that offer a verified, reproducible, and renewable source of positive/negative controls where the expression of the target biomarker is confirmed for accuracy and specificity by an immunoassay. Researchers, antibody and assay developers, and immunohistochemistry (IHC) labs often have difficulty finding a reliable and verified source of positive/negative controls for their IHC experiments. AMSBIO's new cytosections range consists of high-quality FFPE sections of cell pellets of ove...
Source: sciencemag.org